THE POTENTIAL OF INTERFERONS IN MALIGNANT DISEASE

被引：11

作者：

OKITA, K ^{[1
]}

KANEKO, T ^{[1
]}

机构：

[1] YAMAGUCHI UNIV,SCH MED,DEPT INTERNAL MED 3,UBE,YAMAGUCHI 755,JAPAN

来源：

DRUGS | 1990年 / 39卷 / 01期

关键词：

D O I：

10.2165/00003495-199039010-00001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：1 / 6

页数：6

共 49 条

[1]

AHRE A, 1984, CANCER TREAT REP, V68, P1331

[2]

AKIYAMA Y, 1984, CANCER RES, V44, P5127

[3] THE EFFECTS OF INTERFERON ON THE FATTY-ACIDS IN UNINFECTED CELLS [J].

APOSTOLOV, K ;

BARKER, W .

FEBS LETTERS, 1981, 126 (02) :261-264

[4] REDUCTION IN THE STEARIC TO OLEIC-ACID RATIO IN LEUKEMIC-CELLS - A POSSIBLE CHEMICAL MARKER OF MALIGNANCY [J].

APOSTOLOV, K ;

BARKER, W ;

CATOVSKY, D ;

GOLDMAN, J ;

MATUTES, E .

BLUT, 1985, 50 (06) :349-354

[5] HUMAN FIBROBLAST INTERFERON FOR CLINICAL-TRIALS - PHARMACOKINETICS AND TOLERABILITY IN EXPERIMENTAL-ANIMALS AND HUMANS [J].

BILLIAU, A ;

DESOMER, P ;

EDY, VG ;

DECLERCQ, E ;

HEREMANS, H .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (01) :56-63

[6] A PHASE-I TRIAL OF INTRAPERITONEAL RECOMBINANT GAMMA-INTERFERON IN ADVANCED OVARIAN-CARCINOMA [J].

DACQUISTO, R ;

MARKMAN, M ;

HAKES, T ;

RUBIN, S ;

HOSKINS, W ;

LEWIS, JL .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (04) :689-695

[7]

EDMONSON JH, 1987, CANCER TREAT REP, V71, P747

[8]

Finter N B, 1981, Methods Enzymol, V78, P14

[9] PHASE-II TRIAL OF RECOMBINANT LEUKOCYTE A INTERFERON IN PATIENTS WITH ADVANCED CHRONIC LYMPHOCYTIC-LEUKEMIA [J].

FOON, KA ;

BOTTINO, GC ;

ABRAMS, PG ;

FER, MF ;

LONGO, DL ;

SCHOENBERGER, CS ;

OLDHAM, RK .

AMERICAN JOURNAL OF MEDICINE, 1985, 78 (02) :216-220

[10] MECHANISM OF ANTITUMOR EFFECT OF INTERFERON IN MICE [J].

GRESSER, I ;

BROUTYBO.D ;

MAURY, C .

NATURE, 1972, 239 (5368) :167-&

← 1 2 3 4 5 →